Vaccinex, Inc. (NASDAQ:VCNX – Get Free Report)’s share price dropped 16.2% on Monday . The stock traded as low as $0.61 and last traded at $0.62. Approximately 2,487 shares changed hands during mid-day trading, a decline of 12% from the average daily volume of 2,818 shares. The stock had previously closed at $0.74.
Vaccinex Stock Down 16.2%
The company has a market cap of $1.61 million, a P/E ratio of -0.01 and a beta of 1.10. The firm’s 50 day moving average is $0.66 and its two-hundred day moving average is $0.74.
Vaccinex Company Profile
Vaccinex, Inc, a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D.
Featured Articles
- Five stocks we like better than Vaccinex
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- Dividend Payout Ratio Calculator
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- This ETF Weeds Out Small-Cap Underperformers
Receive News & Ratings for Vaccinex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vaccinex and related companies with MarketBeat.com's FREE daily email newsletter.
